Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.4K Sell
22,128
-1,647
-7% -$7.27K ﹤0.01% 3742
2026
Q1
$85.8K Sell
23,775
-689
-3% -$2.38K ﹤0.01% 3643
2025
Q4
$83.4K Buy
24,464
+3,870
+19% +$18.8K ﹤0.01% 3653
2025
Q3
$140K Sell
20,594
-306,486
-94% -$2.53M ﹤0.01% 3631
2025
Q2
$4.45M Buy
327,080
+310,759
+1,904% +$2.93M ﹤0.01% 2249
2025
Q1
$88.8K Sell
16,321
-606
-4% -$3.44K ﹤0.01% 3641
2024
Q4
$83.8K Buy
16,927
+711
+4% +$3.73K ﹤0.01% 3645
2024
Q3
$85K Sell
16,216
-15,187
-48% -$87.6K ﹤0.01% 3640
2024
Q2
$215K Sell
31,403
-1,134,284
-97% -$10.4M ﹤0.01% 3601
2024
Q1
$12M Buy
1,165,687
+314,396
+37% +$2.32M ﹤0.01% 1722
2023
Q4
$7.06M Buy
+851,291
New +$6.12M ﹤0.01% 2044
2021
Q2
Sell
-424,626
Closed -$6.72M 4004
2021
Q1
$6.72M Buy
+424,626
New +$7.64M ﹤0.01% 2208

Other funds holding LFMD

Invesco's LFMD Position: Q2 2026 in Review

Invesco reduced its LifeMD (LFMD) stake by 6.9% in Q2 2026, selling an estimated $7.27K and leaving 22,128 shares worth $91.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3742.

Invesco first reported a position in LFMD in Q1 2021 and has held it in 12 quarters since. The position peaked at $12M in Q1 2024. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Invesco held 22,128 shares of LifeMD worth $91.4K as of Q2 2026.
  • Invesco sold 1,647 LifeMD shares in Q2 2026, an estimated $7.27K.
  • LifeMD made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3742 holding.
  • Invesco first reported a position in LifeMD in Q1 2021 and has held it in 12 quarters since.
  • Invesco's LifeMD position peaked at $12M in Q1 2024.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.